ENSG
Next earnings: Jul 23, 2026 · After close
Signal
Leaning Bearish1!
Price
1
Move+0.06%Quiet session
Volume
1
Volume0.1× avgLight volume
Technical
1
RSIRSI 81Overbought
PRICE
Prev Close
175.95
Open
176.54
Day Range174.93 – 178.80
174.93
178.80
52W Range129.91 – 218.00
129.91
218.00
52% of range
VOLUME & SIZE
Avg Volume
443.3K
FUNDAMENTALS
P/E Ratio
28.7x
EPS (TTM)
Div Yield
0.00%
Beta
0.68
Low vol
Performance
1D
-3.34%
5D
-5.12%
1M
-11.13%
3M
-10.76%
6M
-7.36%
YTD
+1.00%
1Y
+33.52%
Best: 1Y (+33.52%)Worst: 1M (-11.13%)
Quick Read
TrendInsufficient MA data
Momentum
NEUTRAL
rev +19% · 14% gross margin
Valuation
EXPENSIVE
P/E 29x vs ~20x sector
Health
STRONG
CR 1.6 · FCF $7.03/sh
Lean Bullish
Key MetricsTTM
Market Cap$10.29B
Revenue TTM$5.27B
Net Income TTM$363.36M
Free Cash Flow$406.10M
Gross Margin13.9%
Net Margin6.9%
Operating Margin8.5%
Return on Equity16.6%
Return on Assets6.5%
Debt / Equity0.95
Current Ratio1.56
EPS TTM$6.29
Alpha SignalsFull Analysis →
What Moves This Stock

Same-store occupancy trends across the portfolio (currently estimated 82-85% vs pre-pandemic 87-89%), as 100bps occupancy improvement translates to $15-20M annual EBITDA

Acquisition pipeline execution and integration success rates—company targets $150-250M annual acquisition spend at 5-6x EBITDA with 18-24 month payback periods

Medicare reimbursement rate updates (annual market basket increases typically 2-3%) and state Medicaid rate adequacy, particularly in California and Texas which represent 40%+ of facilities

Labor cost inflation and staffing availability, as nursing wages represent 55-60% of operating costs and CNA shortages can limit census growth

Macro Sensitivity
Economic Cycle

low - Post-acute care demand is driven by demographic trends (aging population, 10,000 Americans turning 65 daily through 2030) and hospital discharge patterns rather than GDP growth. However, private pay assisted living occupancy shows modest correlation to consumer confidence and housing wealth effects, as families' willingness to pay $4,000-7,000/month depends on financial security. Recessions can accelerate Medicaid conversions as private pay residents spend down assets, shifting payor mix but maintaining occupancy.

Interest Rates

Rising rates create moderate headwinds through two channels: (1) Higher acquisition financing costs—ENSG uses variable-rate credit facilities for acquisitions, so 100bps rate increase adds $1-2M annual interest expense on $150-200M acquisition debt; (2) Valuation multiple compression as healthcare REITs and yield-oriented investors rotate to bonds, though this is partially offset by ENSG's growth profile. Conversely, lower rates reduce financing costs and support higher acquisition multiples. The company's 1.86x debt/equity ratio implies moderate balance sheet sensitivity.

Key Risks

Medicare and Medicaid reimbursement policy changes—CMS could implement rate cuts, modify PDPM acuity adjustments, or impose quality-based payment penalties that compress margins. State budget pressures (particularly California, Texas) could freeze or reduce Medicaid rates below cost inflation.

Regulatory staffing mandates—CMS proposed minimum nurse staffing ratios (0.55 RN hours and 2.45 total nurse hours per resident day) would require $50-100M annual incremental labor costs across the portfolio if implemented without corresponding reimbursement increases

Demographic concentration risk—70% of facilities are in Western states where housing costs and wage inflation exceed national averages, creating higher operating cost structures. California regulatory environment (AB 1502 seismic retrofits, SB 525 healthcare wage floors) adds state-specific compliance costs.

Investor Profile

growth - The stock attracts growth-at-reasonable-price (GARP) investors seeking exposure to demographic tailwinds (aging population) with visible 15-20% annual earnings growth driven by operational improvements and accretive M&A. The 66% one-year return reflects multiple expansion as investors reward consistent execution of the acquisition-and-turnaround model. Limited dividend yield (estimated <1%) means income investors are underrepresented. Institutional ownership likely concentrated in healthcare-focused funds and small/mid-cap growth managers.

Watch on Earnings
CMS Medicare Advantage penetration rate (currently ~50% of Medicare beneficiaries)—higher MA penetration shifts reimbursement from fee-for-service to managed care contracts with 5-10% lower ratesBureau of Labor Statistics healthcare wage inflation (RN and CNA hourly wages)—nursing labor represents 55-60% of costs, so wage growth exceeding reimbursement rate increases compresses marginsState Medicaid budget allocations for long-term care in California, Texas, Arizona—these three states represent 50%+ of ENSG facilities and Medicaid rate adequacy varies significantly by state fiscal healthUS Census Bureau 65+ population growth rate and 85+ cohort projections—the 85+ population (highest nursing home utilization) is projected to grow 3-4% annually through 2035
Health Radar
3 strong2 watch1 concern
55/100
Liquidity
1.56Watch
Leverage
0.95Strong
Coverage
56.9xStrong
ROE
16.6%Strong
ROIC
7.0%Concern
Cash
$504MWatch
ANALYST COVERAGE13 analysts
BUY
+26.1%upside to target
L $215.00
Med $222.00consensus
H $230.00
Buy
969%
Hold
215%
Sell
215%
9 Buy (69%)2 Hold (15%)2 Sell (16%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
6/10
Technicals
RSI RangeRSI 81 — Overbought, caution
~
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 1.56 — healthy liquidity
Upcoming Events
EEarnings ReportMay 7, 2026
Tomorrow
DEx-Dividend DateAug 4, 2026
In 90 days
PDividend PaymentSep 1, 2026
In 118 days
Technicals
Technical SetupMIXED
Technicals →

Trend

PullbackGolden Cross · 50D leads 200D by 36.1%

-3.3% vs SMA 50 · +31.7% vs SMA 200

Momentum

RSI80.7
Overbought — pullback risk
MACD+2.91
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$218.0+23.8%
EMA 50
$180.4+2.4%
Current
$176.1
EMA 200
$134.1-23.8%
52W Low
$129.9-26.2%
52-Week RangeMid-range
$129.952th %ile$218.0
Squeeze SetupVolume-based
Distribution Pressure

Heavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.

20-Day Money Flow
Acc days:2
Dist days:5
Edge:+3 dist
Volume Context
Avg Vol (50D)383K
Recent Vol (5D)
489K+28%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 5 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$4.0B
$4.0B$4.0B
$4.01
±0%
Moderate3
FY2024
$4.3B
$4.2B$4.3B
+7.3%$5.49+36.9%
±0%
High5
FY2025
$5.1B
$5.1B$5.1B
+19.0%$6.52+18.8%
±0%
Moderate4
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 8 consecutive quarters
Earnings HistoryENSG
Last 8Q
+2.3%avg beat
Beat 8 of 8 quarters Estimates rising
+2%
Q3'24
+1%
Q4'24
+1%
Q1'25
+2%
Q2'25
+3%
Q3'25
+3%
Q4'25
+4%
Q1'26
+3%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $98K sold · 30d window
Agwunobi John ODir
$78K
Apr 20
SELL
Parkinson Mark Vinc…Dir
$20K
Apr 16
SELL
Smith Barry MDir
$138K
Apr 2
SELL
Smith Barry MDir
$149K
Mar 2
SELL
Uychiat Pison Mariv…Dir
$18K
Feb 19
SELL
Uychiat Pison Mariv…Dir
$14K
Feb 20
SELL
Financials
Dividends0.14% yield
+4.7% avg annual growth
Annual Yield0.14%
Quarterly Div.$0.0650
Est. Annual / Share$0.26
FrequencyQuarterly
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
WASATCH ADVISORS LP
2.1M
2
RIVERBRIDGE PARTNERS LLC
569K
3
Bank of New York Mellon Corp
455K
4
ENVESTNET ASSET MANAGEMENT INC
358K
5
Candriam S.C.A.
260K
6
Nuveen, LLC
253K
7
ProShare Advisors LLC
184K
8
GAGNON SECURITIES LLC
180K
News & Activity

ENSG News

20 articles · 4h ago

About

skilled nursing/assisted living

CEO
Barry Port
Kevin ReesePresident of Keystone Healthcare Inc
Chad A. KeetchChief Investment Officer, Executive Vice President & Secretary
Beverly WittekindExecutive Vice President & General Counsel
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
ENSG
$176.05-3.34%$10.3B28.0+1871.5%680.1%1500
$68.19-0.30%$13.3B+12626.1%-14525.8%1500
$92.42-1.81%$11.7B+3288.2%-4239.0%1500
$530.45-3.12%$11.5B+43205.3%-3008.0%1500
$222.41-0.29%$11.4B+6554.5%-2868.8%1500
$78.11-1.91%$10.5B51.9+2325815.3%-19.7%1500
$52.63-3.92%$10.2B34.0+1459.3%147.7%1500
Sector avg-2.10%37.9+342117.2%-3404.8%1500